VirTra Training Simulators Approved for Use by the Royal Canadian Mounted Police
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 01 2025
0mins
Should l Buy VTSI?
Source: Newsfilter
RCMP Deployment of VirTra Simulators: The Royal Canadian Mounted Police has fully deployed 20 VirTra training simulators after successful field testing, marking a significant milestone for the company in the Canadian law enforcement market.
Training Technology Approval: VirTra's new recoil kits and advanced skills magazines received full approval during rigorous testing, enhancing the realism and effectiveness of training for RCMP officers, which may lead to further system purchases across Canada.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VTSI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VTSI
Wall Street analysts forecast VTSI stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 4.500
Low
7.00
Averages
8.25
High
9.50
Current: 4.500
Low
7.00
Averages
8.25
High
9.50
About VTSI
VirTra, Inc. is a provider of judgmental use of force training simulators and firearms training simulators for the law enforcement, military, and commercial markets. Its patented technologies, software, and scenarios provide intense training for de-escalation, judgmental use-of-force, marksmanship, and related training that mimics real-world situations. Its segments include Simulators and Accessories, Extended Service-type warranties, Customized software and content, Installation and training, Design and Prototyping, and Subscription Training Equipment Partnership (STEP). Installation and training segment include installation of its simulators at specific sites as well as extra training classes preformed onsite, virtually or at the training center. Simulators and Accessories segment includes all variations of the its simulator, simulated recoil kits, Taser, OC Spray, low light devices and refill options. Design and Prototyping segment includes contracts related to hardware development.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
VirTra (VTSI) to Showcase Advanced Simulators at 2026 SHOT Show
- Event Participation: VirTra will showcase its V-300®, V-One™, and V-XR® simulators at the 2026 SHOT Show from January 20-23 in Las Vegas, expected to attract numerous industry professionals.
- Technology Demonstration: During the event, VirTra will conduct live demonstrations highlighting the realism and adaptability of its simulation technologies, aiding law enforcement and military personnel in decision-making training under high-pressure scenarios.
- Market Positioning: The SHOT Show is the world's largest trade event for shooting sports and law enforcement, and VirTra's participation will enhance its influence in the industry while showcasing its leadership in training solutions.
- Customer Engagement: VirTra CEO John Givens emphasized that the SHOT Show provides a valuable opportunity for the company to engage with global customers and industry leaders, demonstrating the realistic scenarios and decision-making capabilities of its comprehensive training platforms.
See More
VirTra Faces Securities Fraud Investigation After Q3 Earnings Miss
- Performance Decline: VirTra reported a GAAP earnings per share of -$0.03 for Q3 2025, missing the consensus estimate by $0.07, indicating significant financial pressure amid a slower federal funding cycle.
- Revenue Gap: The company's revenue of $5.3 million fell short of consensus by $1.69 million, reflecting the impact of customer acceptances and timing of federal awards on near-term revenue recognition, which may erode investor confidence.
- Stock Price Reaction: Following the earnings report, VirTra's stock price dropped by $0.43, or 7.93%, closing at $4.99 on November 11, 2025, signaling market concerns regarding the company's financial health.
- Legal Investigation: Pomerantz LLP is investigating whether VirTra and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and potential financial liabilities, impacting the company's future operations and reputation.
See More
VirTra Faces Investigation After Q3 Earnings Miss, Stock Drops 7.93%
- Earnings Miss: VirTra reported a GAAP EPS of -$0.03 for Q3 2025, missing the consensus estimate by $0.07, while revenue of $5.3 million fell short of expectations by $1.69 million, indicating challenges amid a slower federal funding cycle.
- Stock Reaction: Following the disappointing earnings report, VirTra's stock price dropped by $0.43, or 7.93%, closing at $4.99 per share on November 11, 2025, reflecting market concerns about the company's future growth prospects.
- Investigation Launched: Pomerantz LLP is investigating whether VirTra and its executives engaged in securities fraud or other unlawful business practices, which could further undermine investor confidence and exacerbate stock volatility.
- Management Statement: The CEO noted that the timing of federal awards and customer acceptances affected near-term revenue recognition, highlighting the company's vulnerability in navigating external economic changes.
See More
VirTra Faces Investigation After Q3 Earnings Miss, Stock Drops 7.93%
- Earnings Miss: VirTra reported a GAAP earnings per share of -$0.03 for Q3 2025, missing the consensus estimate by $0.07, indicating challenges in revenue recognition amid a slower federal funding cycle, which has negatively impacted investor confidence.
- Revenue Decline: The company's revenue of $5.3 million fell short of consensus by $1.69 million, reflecting delays in customer acceptances and federal award timing, which may lead to uncertainty in future performance.
- Stock Reaction: Following the earnings report, VirTra's stock price dropped by $0.43, or 7.93%, closing at $4.99 per share on November 11, 2025, highlighting market concerns regarding the company's financial health.
- Legal Investigation: Pomerantz LLP is investigating whether VirTra and its executives engaged in securities fraud or other unlawful business practices, which could further negatively impact the company's reputation and future stock price.
See More
VirTra Reports Q3 Earnings Miss, Stock Drops 7.93%
- Earnings Miss: VirTra reported a GAAP EPS of -$0.03 for Q3 2025, missing the consensus estimate by $0.07, indicating significant challenges in revenue growth amid a slower federal funding cycle.
- Revenue Decline: The company's revenue of $5.3 million fell short of the consensus of $6.99 million, reflecting the impact of federal award timing and customer acceptances on near-term revenue recognition, which may erode investor confidence.
- Stock Reaction: Following the earnings report, VirTra's stock price dropped by $0.43, or 7.93%, closing at $4.99 per share on November 11, 2025, signaling market concerns regarding the company's financial health.
- Legal Investigation: Pomerantz LLP is investigating whether VirTra and its executives engaged in securities fraud or other unlawful business practices, which could further impact the company's future legal and financial standing.
See More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of VirTra, Inc. - VTSI
Investigation Announcement: Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving VirTra, Inc. and its officers/directors, urging affected investors to contact them.
Financial Performance: VirTra reported disappointing third-quarter financial results, with a GAAP earnings per share of -$0.03 and revenue of $5.3 million, both missing consensus estimates, leading to a significant drop in stock price.
CEO's Statement: The CEO attributed the revenue shortfall to a slower federal funding cycle and delays in federal awards and customer acceptances affecting revenue recognition.
Pomerantz LLP Background: Pomerantz LLP is a well-established law firm specializing in corporate, securities, and antitrust class litigation, with a history of recovering substantial damages for victims of securities fraud and corporate misconduct.
See More
VirTra (VTSI) to Showcase Advanced Simulators at 2026 SHOT Show
- Event Participation: VirTra will showcase its V-300®, V-One™, and V-XR® simulators at the 2026 SHOT Show from January 20-23 in Las Vegas, expected to attract numerous industry professionals.
- Technology Demonstration: During the event, VirTra will conduct live demonstrations highlighting the realism and adaptability of its simulation technologies, aiding law enforcement and military personnel in decision-making training under high-pressure scenarios.
- Market Positioning: The SHOT Show is the world's largest trade event for shooting sports and law enforcement, and VirTra's participation will enhance its influence in the industry while showcasing its leadership in training solutions.
- Customer Engagement: VirTra CEO John Givens emphasized that the SHOT Show provides a valuable opportunity for the company to engage with global customers and industry leaders, demonstrating the realistic scenarios and decision-making capabilities of its comprehensive training platforms.
See More
VirTra Faces Securities Fraud Investigation After Q3 Earnings Miss
- Performance Decline: VirTra reported a GAAP earnings per share of -$0.03 for Q3 2025, missing the consensus estimate by $0.07, indicating significant financial pressure amid a slower federal funding cycle.
- Revenue Gap: The company's revenue of $5.3 million fell short of consensus by $1.69 million, reflecting the impact of customer acceptances and timing of federal awards on near-term revenue recognition, which may erode investor confidence.
- Stock Price Reaction: Following the earnings report, VirTra's stock price dropped by $0.43, or 7.93%, closing at $4.99 on November 11, 2025, signaling market concerns regarding the company's financial health.
- Legal Investigation: Pomerantz LLP is investigating whether VirTra and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and potential financial liabilities, impacting the company's future operations and reputation.
See More
VirTra Faces Investigation After Q3 Earnings Miss, Stock Drops 7.93%
- Earnings Miss: VirTra reported a GAAP EPS of -$0.03 for Q3 2025, missing the consensus estimate by $0.07, while revenue of $5.3 million fell short of expectations by $1.69 million, indicating challenges amid a slower federal funding cycle.
- Stock Reaction: Following the disappointing earnings report, VirTra's stock price dropped by $0.43, or 7.93%, closing at $4.99 per share on November 11, 2025, reflecting market concerns about the company's future growth prospects.
- Investigation Launched: Pomerantz LLP is investigating whether VirTra and its executives engaged in securities fraud or other unlawful business practices, which could further undermine investor confidence and exacerbate stock volatility.
- Management Statement: The CEO noted that the timing of federal awards and customer acceptances affected near-term revenue recognition, highlighting the company's vulnerability in navigating external economic changes.
See More
VirTra Faces Investigation After Q3 Earnings Miss, Stock Drops 7.93%
- Earnings Miss: VirTra reported a GAAP earnings per share of -$0.03 for Q3 2025, missing the consensus estimate by $0.07, indicating challenges in revenue recognition amid a slower federal funding cycle, which has negatively impacted investor confidence.
- Revenue Decline: The company's revenue of $5.3 million fell short of consensus by $1.69 million, reflecting delays in customer acceptances and federal award timing, which may lead to uncertainty in future performance.
- Stock Reaction: Following the earnings report, VirTra's stock price dropped by $0.43, or 7.93%, closing at $4.99 per share on November 11, 2025, highlighting market concerns regarding the company's financial health.
- Legal Investigation: Pomerantz LLP is investigating whether VirTra and its executives engaged in securities fraud or other unlawful business practices, which could further negatively impact the company's reputation and future stock price.
See More
VirTra Reports Q3 Earnings Miss, Stock Drops 7.93%
- Earnings Miss: VirTra reported a GAAP EPS of -$0.03 for Q3 2025, missing the consensus estimate by $0.07, indicating significant challenges in revenue growth amid a slower federal funding cycle.
- Revenue Decline: The company's revenue of $5.3 million fell short of the consensus of $6.99 million, reflecting the impact of federal award timing and customer acceptances on near-term revenue recognition, which may erode investor confidence.
- Stock Reaction: Following the earnings report, VirTra's stock price dropped by $0.43, or 7.93%, closing at $4.99 per share on November 11, 2025, signaling market concerns regarding the company's financial health.
- Legal Investigation: Pomerantz LLP is investigating whether VirTra and its executives engaged in securities fraud or other unlawful business practices, which could further impact the company's future legal and financial standing.
See More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of VirTra, Inc. - VTSI
Investigation Announcement: Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving VirTra, Inc. and its officers/directors, urging affected investors to contact them.
Financial Performance: VirTra reported disappointing third-quarter financial results, with a GAAP earnings per share of -$0.03 and revenue of $5.3 million, both missing consensus estimates, leading to a significant drop in stock price.
CEO's Statement: The CEO attributed the revenue shortfall to a slower federal funding cycle and delays in federal awards and customer acceptances affecting revenue recognition.
Pomerantz LLP Background: Pomerantz LLP is a well-established law firm specializing in corporate, securities, and antitrust class litigation, with a history of recovering substantial damages for victims of securities fraud and corporate misconduct.
See More
